1. Home
  2. CVSA

as of 08-27-2026 4:00pm EST

$140.68
+$2.90
+2.10%
Stocks Real Estate Other Consumer Services Nasdaq

Covista Inc is an American healthcare educator, serving more than 97,000 students and supported by a community of alumni across five accredited institutions. Through personalized, tech-enabled education powered by faculty and colleagues, it expands access to healthcare careers and addresses the U.S. healthcare workforce shortage at scale.

Founded: 1987 Country:
United States
United States
Employees: N/A City: CHICAGO
Market Cap: 4.3B IPO Year: 1995
Target Price: $150.00 AVG Volume (30 days): 325.0K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: quarterly
EPS: 7.04 EPS Growth: 13.92
52 Week Low/High: $96.08 - $141.91 Next Earning Date: 05-07-2026
Revenue: $1,954,085,000 Revenue Growth: 9.27%
Revenue Growth (this year): 9.66% Revenue Growth (next year): 6.58%
P/E Ratio: 19.57 Index: N/A
Free Cash Flow: 392.7M FCF Growth: +57.39%

Stock Insider Trading Activity of Covista Inc. Common Shares (CVSA)

Beard, Stephen W.

Chairman & CEO

Sell
CVSA Aug 11, 2026

Avg Cost/Share

$130.35

Shares

3,545

Total Value

$462,073.03

Owned After

415,197

SEC Form 4

Phelan Robert J.

Chief Financial Officer

Sell
CVSA Aug 7, 2026

Avg Cost/Share

$135.15

Shares

2,186

Total Value

$295,437.90

Owned After

48,306

SEC Form 4

BECK DOUGLAS G.

SVP, GC, Corp. Sec & ISS

Sell
CVSA Aug 7, 2026

Avg Cost/Share

$135.81

Shares

4,526

Total Value

$614,676.06

Owned After

28,544

SEC Form 4

Earnings Transcripts

SEC 8-K filings with transcript text

View All
2026
Q2

Q2 2026 Earnings

8-K

Aug 6, 2026

0000730464-26-000037

Transcript text not available. View on SEC.gov →

2026
Q1

Q1 2026 Earnings

8-K

May 7, 2026

0000730464-26-000021

Transcript text not available. View on SEC.gov →

2025
Q4

Q4 2025 Earnings

8-K

Jan 28, 2026

0000730464-26-000003

Transcript text not available. View on SEC.gov →

Share on Social Networks: